Dr. David Dongeun Chang, MD
- Publications
- 1
- Clinical trials
- 6
- Industry payments
- $155
- Affiliated sites
- 1
- Medical group
- 1
- Practice address
- 36485 Inland Valley Dr, Wildomar, CA 92595
- Practice phone
- Call (610) 768-3300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Southwest Healthcare Inland Valley Hospital
Wildomar, California
Find Dr. Chang's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David Dongeun Chang is a hematologist and oncologist in Wildomar, California
Dr. Chang practices at Southwest Healthcare Inland Valley Hospital in Wildomar, California.
Dr. Chang's NPI, 1952336737, was assigned on July 11, 2006. Dr. Chang holds California license G78979.
- NPI
- 1952336737NPI Registry (opens in a new tab)
- NPI enumeration date
- July 11, 2006
- NPI status
- Active
- Practice phone
- (610) 768-3300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. David Dongeun Chang practices at Southwest Healthcare Inland Valley Hospital in Wildomar, California
Dr. Chang's primary practice is Southwest Healthcare Inland Valley Hospital, at 36485 Inland Valley Dr, Wildomar, CA 92595 in Riverside County. The practice phone is (610) 768-3300.
- Southwest Healthcare Inland Valley Hospital36485 Inland Valley Dr, Wildomar, CA 92595 · Riverside CountyPhone(610) 768-3300
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. David Dongeun Chang is affiliated with 2 sites of care and 1 medical group
Dr. Chang's primary practice is Southwest Healthcare Inland Valley Hospital in Wildomar, California. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Chang to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. David Dongeun Chang's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Southwest Healthcare Inland Valley Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David Dongeun Chang is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chang is licensed in California.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
Hematologists and oncologists near Dr. Chang
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David Dongeun Chang's patients have a median age of 59
Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 59, with 41% women.
Dr. Chang's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 59
Patient panel by sex, all payers
- Women41%
- Men59%
Source: Dmand AI Patient Panel Data
Dr. David Dongeun Chang has 1 publication on record
Dmand AI links 1 paper to Dr. Chang in 2018. Dr. Chang's most frequent co-author is Jerry Lee, MD.
Dr. Chang's most frequent co-authors
Recent publications by Dr. Chang
See who Dr. Chang researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Chang works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David Dongeun Chang has worked on 6 clinical trials
Dmand AI links Dr. Chang to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Hepatocellular. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Chang that name 6 trials.
Conditions in Dr. Chang's trials
- Breast Neoplasms
- Breast Diseases
- Carcinoma, Hepatocellular
- Delirium
- Urethral Neoplasms
Investigators on the most trials with Dr. Chang
- Robert Andrew Dichmann, MD4 shared trials
- Maura N. Dickler, MD4 shared trials
- Jeremy Goodrich Perkins, MD3 shared trials
Recent clinical trials with Dr. Chang
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David Dongeun Chang received $155 in industry payments in 2017
CMS Open Payments shows 2 general payments to Dr. Chang from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Daiichi Sankyo Company LTD paid the most, $155. It also lists 11 research payments totaling $22,413 from 2016 to 2023, naming 6 clinical trials.
Companies that paid Dr. Chang the most, 2017 to 2017
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. David Dongeun Chang's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David Dongeun Chang
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David Dongeun Chang's NPI number?
Dr. David Dongeun Chang's NPI number is 1952336737. It was assigned on July 11, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. David Dongeun Chang?
Dr. David Dongeun Chang is a hematologist and oncologist in Wildomar, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. David Dongeun Chang practice?
Dr. Chang practices at 36485 Inland Valley Dr, Wildomar, CA 92595. Dr. Chang's primary practice is Southwest Healthcare Inland Valley Hospital in Wildomar, California. Dmand AI also links Dr. Chang to 1 group practice or clinic.
What is Dr. David Dongeun Chang's office phone number?
The practice phone on file for Dr. Chang is (610) 768-3300.
What is Dr. David Dongeun Chang's medical license number?
Dr. Chang holds California license G78979.
What medical group is Dr. David Dongeun Chang part of?
Dr. Chang is linked to UCLA Medical Group.
Has Dr. David Dongeun Chang received payments from drug or device companies?
CMS Open Payments shows $155 in general payments to Dr. Chang from 1 company from 2017 to 2017. The largest total came from Daiichi Sankyo Company LTD.
How long has Dr. David Dongeun Chang been practicing?
Dr. Chang's NPI was assigned in 2006.
Does Dr. David Dongeun Chang do research?
Dmand AI links 1 publication to Dr. Chang. Dr. Chang has worked on 6 clinical trials.
Who does Dr. David Dongeun Chang publish with?
Dr. Chang's most frequent co-authors are Jerry Lee, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card